Woehlke G, Schliwa M (2000) Walking on two heads: the many talents of kinesin. Nat Rev Mol Cell Biol 1(1):50–58 DOI: 10.1038/35036069
Bacquet J, Stojkovic T, Boyer A, Martini N, Audic F, Chabrol B, et al. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open 2018;8(10):e021632
Nam DE, Yoo DH, Choi SS, Choi BO, Chung KW. Wide phenotypic spectrum in axonal Charcot–Marie–Tooth neuropathy type 2 patients with KIF5A mutations. Genes Genom [Internet]. 2018;40(1):77–84. 10.1007/s13258-017-0612-x
Liu YT, Laurá M, Hersheson J, Horga A, Jaunmuktane Z, Brandner S et al (2014) Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy. Neurology 83(7):612–619 DOI: 10.1212/WNL.0000000000000691
Nicolas A, Kenna K, Renton AE, Ticozzi N, Faghri F, Chia R et al (2018) Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97(6):1268–1283 DOI: 10.1016/j.neuron.2018.02.027
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424 DOI: 10.1038/gim.2015.30
Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G et al (2012) Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet 82(2):157–164 DOI: 10.1111/j.1399-0004.2011.01717.x
Ando M, Hashiguchi A, Okamoto Y, Yoshimura A, Hiramatsu Y, Yuan J et al (2017) Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. J Peripher Nerv Syst 22(3):191–199 DOI: 10.1111/jns.12228
